Dr. Ido Bachelet (far right), of the Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, addresses the gathering
Suiting up for Science
Date: 2014-11-11 Hour: 9:09
Dr. Ido Bachelet, of the Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, recently brought good news to London. Clinical trials may soon begin on the nanorobots he has developed to fight cancer.
The nanorobots, which can be injected into patients, are able to identify and kill cancer cells without affecting healthy cells. So far, the robots can recognize a dozen types of cancer, including leukemias and solid tumors, the London Jewish Chronicle reported.
Bachelet revealed the news to a group of distinguished guests – mostly Russians – who've settled, or have homes, in London. The gathering was hosted by the British Friends of Bar-Ilan University (BFBIU) at Otto Uomo, an Italian luxury menswear store in Mayfair.
The research being conducted today at the Goodman Faculty of Life Sciences "could revolutionize everything we know as medicine," Bachelet, a returning scientist from MIT who completed a postdoctoral fellowship at Harvard Medical School, told the group.
Dr. Bachelet's nanorobots, developed from molecular DNA, can also help epileptics and check when diabetes sufferers need insulin and how much. He has given three demonstrations of the robots to the US Food and Drug Administration.
Of the event, BFBIU Executive Director Shlomo Rechtschaffen said, "Bar-Ilan is constantly expanding its circle of friends. This event increased the exposure of the University's work to a distinct and discerning expat community."